Hot Pursuit     05-Oct-21
Gland Pharma Ltd spurts 3.65%, up for five straight sessions
Gland Pharma Ltd is quoting at Rs 4019.9, up 3.65% on the day as on 12:49 IST on the NSE. The stock is up 120.93% in last one year as compared to a 52.07% gain in NIFTY and a 22.68% gain in the Nifty Pharma.

Gland Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 4019.9, up 3.65% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.25% on the day, quoting at 17734.9. The Sensex is at 59425.67, up 0.21%. Gland Pharma Ltd has added around 0.76% in last one month.

Meanwhile, Nifty Pharma index of which Gland Pharma Ltd is a constituent, has added around 1.73% in last one month and is currently quoting at 14812.4, down 0.54% on the day. The volume in the stock stood at 1.17 lakh shares today, compared to the daily average of 1.75 lakh shares in last one month.

The PE of the stock is 61.45 based on TTM earnings ending June 21.

Previous News
  Stock alert: Gland Pharma, Gujarat Fluorochem, Ujjivan SFB, Prestige Estates, IREDA
 ( Market Commentary - Stock Alert 24-Jun-24   08:41 )
  Benchmarks trade with significant gains; VIX tumbles 9.39%
 ( Market Commentary - Mid-Session 07-Aug-24   12:36 )
  Gland Pharma receives USFDA approval for Cetrorelix Acetate for Injection
 ( Corporate News - 29-Apr-24   10:49 )
  Gland Pharma allots 6,200 equity shares under ESOS
 ( Corporate News - 14-Feb-24   15:10 )
  Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr
 ( Hot Pursuit - 07-Aug-24   11:27 )
  Gland Pharma's Pashamylaram unit clears USFDA inspection
 ( Corporate News - 24-Nov-23   10:34 )
  Gland Pharma consolidated net profit declines 15.30% in the June 2023 quarter
 ( Results - Announcements 07-Aug-23   18:19 )
  Gland Pharma Ltd gains for third straight session
 ( Hot Pursuit - 09-Sep-24   13:05 )
  Gland Pharma spurts after Hyderabad facility gets EIR from USFDA
 ( Hot Pursuit - 24-Nov-23   10:58 )
  Gland Pharma Hyderabad facility gets one USFDA observation
 ( Hot Pursuit - 28-Jun-23   09:38 )
  Gland Pharma standalone net profit declines 18.25% in the June 2023 quarter
 ( Results - Announcements 07-Aug-23   18:19 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top